Welcome to Paid Research Studies

  • Conditions:   Migraine in Children;   Posttraumatic Headache
    Interventions:   Drug: Lidocaine 2% Injectable Solution;   Drug: Normal Saline Flush, 0.9% Injectable Solution
    Sponsor:   University of British Columbia
    Not yet recruiting

  • Conditions:   Postoperative Quality of Recovery;   Postoperative Migrainous Headache
    Interventions:   Drug: Sumatriptan;   Drug: Placebo
    Sponsor:   University Health Network, Toronto

  • Conditions:   Headache Disorders;   Post-Concussion Syndrome;   Mild Traumatic Brain Injury
    Intervention:   Other: Education
    Sponsor:   St. Michael's Hospital, Toronto

  • Condition:   Migraine Disorders
    Interventions:   Behavioral: SPHERE;   Behavioral: PRISM
    Sponsors:   IWK Health Centre;   Nova Scotia Health Research Foundation;   Canadian Institutes of Health Research (CIHR)

  • Conditions:   Migraine;   Cluster Headache
    Intervention:   Drug: Fremanezumab
    Sponsor:   Teva Branded Pharmaceutical Products, R&D Inc.

  • Condition:   Migraine
    Intervention:   Other: Aerobic exercise
    Sponsor:   University of Calgary

  • Condition:   Migraine
    Interventions:   Drug: Dexamethasone group;   Drug: Placebo group
    Sponsor:   St. Justine's Hospital

  • Conditions:   Adenovirus;   Anesthesia;   Anxiety;   Anxiolysis;   Autism;   Autistic Disorder;   Bacterial Meningitis;   Bacterial Septicemia;   Benzodiazepine;   Bipolar Disorder;   Bone and Joint Infections;   Central Nervous System Infections;   Convulsions;   Cytomegalovirus Retinitis;   Early-onset Schizophrenia Spectrum Disorders;   Epilepsy;   General Anesthesia;   Gynecologic Infections;   Herpes Simplex Virus;   Infantile Hemangioma;   Infection;   Inflammation;   Inflammatory Conditions;   Intra-abdominal Infections;   Lower Respiratory Tract Infections;   Migraines;   Pain;   Pneumonia;   Schizophrenia;   Sedation;   Seizures;   Skeletal Muscle Spasms;   Skin and Skin-structure Infections;   Treatment-resistant Schizophrenia;   Urinary Tract Infections;   Withdrawal;   Sepsis;   Gram-negative Infection;   Bradycardia;   Cardiac Arrest;   Cardiac Arrhythmia;   Staphylococcal Infections;   Nosocomial Pneumonia;   Neuromuscular Blockade;   Methicillin Resistant Staphylococcus Aureus;   Endocarditis;   Neutropenia;   Headache;   Fibrinolytic Bleeding;   Pulmonary Arterial Hypertension;   CMV Retinitis;   Hypertension;   Chronic Kidney Diseases;   Hyperaldosteronism;   Hypokalemia;   Heart Failure;   Hemophilia;   Heavy Menstrual Bleeding;   Insomnia
    Intervention:   Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
    Sponsors:   Daniel Benjamin;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   The Emmes Company, LLC

  • Condition:   Chronic Migraine
    Interventions:   Drug: Atogepant 30 mg;   Drug: Atogepant 60 mg;   Drug: Placebo
    Sponsor:   Allergan

  • Condition:   Idiopathic Intracranial Hypertension
    Interventions:   Drug: Acetazolamide;   Procedure: Optic Nerve Sheath Fenestration;   Procedure: Ventriculoperitoneal CSF Shunting
    Sponsors:   Jaeb Center for Health Research;   National Eye Institute (NEI);   University of Iowa;   Icahn School of Medicine at Mount Sinai